The US Food and Drug Administration (FDA) has dispatched warning letters to 15 firms, including foreign and domestic to desist from selling their illegally marketed diabetes products. The latest move will help the regulator to curb the ...
Tags: Diabetes'Medicines, active pharma
Indian based pharmaceutical company Cipla has completed the acquisition of Cipla Medpro South Africa for a consideration of ZAR4.507bn ($456.43m). Commenting on the development Cipla managing director and global CEO Subhanu Saxena was ...
Tags: Cipla, Cipla Medpro
The US Food and Drug Administration (FDA) has issued a Class I recall of Medtronic’s MiniMed Paradigm Insulin Infusion Sets. The Paradigm infusion sets are meant for use with Paradigm insulin infusion pumps. These infusion sets are ...
Becton, Dickinson and Company (BD), a medical device company, has invested $4.5m (€3.5m) in a syringe production plant in Ireland. The company has made the investment on new equipment to boost the production of insulin pen needles, ...
Norwegian cardiovascular biopharma Serodus has signed a merger agreement with Danish peptide specialist Phlogo to expand cardiovascular drug candidate portfolio. Subject to approval by an EGM, the merger is expected to accelerate Serodus' ...
NeuroMetrix, a US-based medical device company, has received 510(k) approval from the US Food and Drug Administration (FDA) for its transcutaneous electrical nerve stimulator, called Sensus Pain Management System. Sensus Pain Management ...
Tags: medical device, Pain Management
The European Medicines Agency (EMA) has accepted Eli Lilly and Company and Boehringer Ingelheim's marketing authorisation application (MAA) for a new insulin glargine product, LY2963016, for review. The application has been filed through ...
Vivus has revealed the initial availability of Qsymia (phentermine and topiramate extended-release) capsules CIV in 8,000 Walgreens, Costco and Duane Reade retail pharmacies in the US. Qsymia is indicated as an adjunct to a ...
Tags: Qsymia, Pharmacies, Vivus
Miraculins, a Canada-based medical diagnostic company, has acquired VeraLight's SCOUT DS technology, which screens diabetes by non-invasively measuring changes in the skin composition. These changes in the skin composition indicates ...
Tags: Miraculins, Screening Technology
Ah, Mondays. Wonder why your employees are all yawning and glassy-eyed today? It may be easy to blame it on the hot weather or overindulgences over the weekend, but researchers are pointing fingers at another potential culprit that is ...
Tags: Smartphones, tablet PCs, Computer Products
US-based Medtronic's sensor-augmented insulin pump with Threshold Suspend feature safely reduces nocturnal hypoglycemia without affecting glycated hemoglobin level (HbA1C), a study results show. Threshold Suspend, which is claimed to be ...
Tags: Health, Medicine, Hypoglycemia
BD Medical, a division of Becton, Dickinson and Company, has launched the BD Ultra-Fine Nano 4mm Pen Needle with EasyFlow Technology in US. Making the procedure fast and easy, EasyFlow Technology helps patients in injecting insulin each ...
Tags: Health, Medicine, Medical's Pen Needle
JDRF and Becton, Dickinson and Company (BD) are accelerating the development of new products that combine BD's insulin infusion and glucose sensing technologies through a new three-year collaboration. This commitment is an extension of ...
Our recent recommendation that you might want to skip the new weight-loss drug Belviq has generated a lot of buzz. To follow up, we commissioned two Dartmouth professors to look at the evidence and prepare a Drug Facts box for Belviq, ...
Tags: Belviq, Weight-Loss Drug, Health&Medicine
Mendor, a Finland-based diabetes technology firm, has received CE Mark clearance for its diabetes management cloud-based platform, Mendor Balance. Delivering benefits to patients, health care professionals, payers and the pharma industry, ...